Canlyniadau Chwilio - Kate Newbold

Mireinio'r Canlyniadau
  1. 1
    Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer

    Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer gan Dario Tumino, Francesco Frasca, Kate Newbold

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers

    Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers gan Shreerang Bhide, Kate Newbold, Kevin J. Harrington, Christopher M. Nutting

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

    Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-i... gan Hakim‐Moulay Dehbi, Ujjal K. Mallick, Jonathan Wadsley, Kate Newbold, Clive Harmer, Allan Hackshaw

    Cyhoeddwyd 2018
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer

    2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer gan Laura Fugazzola, Rossella Elisei, Dagmar Führer, Barbara Jarząb, Sophie Leboulleux, Kate Newbold, Johannes W. A. Smit

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up gan Sébastiano Filetti, Cosimo Durante, Dana M. Hartl, Sophie Leboulleux, Laura D. Locati, Kate Newbold, Mauro Papotti, Alfredo Berruti

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

    ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer gan Sébastiano Filetti, Cosimo Durante, Dana M. Hartl, Sophie Leboulleux, Laura D. Locati, Kate Newbold, Mauro Papotti, Alfredo Berruti

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Neurocognitive Function After (Chemo)-Radiotherapy for Head and Neck Cancer

    Neurocognitive Function After (Chemo)-Radiotherapy for Head and Neck Cancer gan Liam Welsh, Alex Dunlop, T. McGovern, Dualta Mcquaid, Jamie Dean, S. Gulliford, Shree Bhide, Kevin J. Harrington, Chris Nutting, Kate Newbold

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Taste dysfunction following radiotherapy to the head and neck: A systematic review

    Taste dysfunction following radiotherapy to the head and neck: A systematic review gan Lucinda Gunn, James Gilbert, Pablo Nenclares, Heba Soliman, Kate Newbold, Shree Bhide, Kee H. Wong, Kevin J. Harrington, Chris Nutting

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Management of Invasive Differentiated Thyroid Cancer

    Management of Invasive Differentiated Thyroid Cancer gan Iain J. Nixon, Ricard Simó, Kate Newbold, Alessandra Rinaldo, Carlos Suárez, Luiz Paulo Kowalski, Carl Silver, Jatin P. Shah, Alfio Ferlito

    Cyhoeddwyd 2016
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei

    Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei gan Magnus T. Dillon, Holly E. Barker, Malin Pedersen, Hind Hafsi, Shreerang Bhide, Kate Newbold, Christopher M. Nutting, Martin McLaughlin, Kevin J. Harrington

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

    Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies gan Enrique Grande, Michael C. Kreißl, Sébastiano Filetti, Kate Newbold, Walter Reinisch, Caroline Robert, Martin Schlumberger, Lærke Kjær Tolstrup, José Luís Zamorano, Jaume Capdevila

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy

    Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radioth... gan Jamie Dean, Kee H. Wong, Liam Welsh, Ann-Britt Jones, Ulrike Schick, Kate Newbold, Shreerang Bhide, Kevin J. Harrington, Christopher M. Nutting, S. Gulliford

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline

    Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline gan Sasha Howard, Sarah Freeston, Barney Harrison, Louise Izatt, Sonali Natu, Kate Newbold, Sabine Pomplun, Helen Spoudeas, Sophie Wilne, Tom Kurzawinski, Mark N. Gaze

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy

    On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy gan Pablo Nenclares, Lucinda Gunn, Heba Soliman, Mateo Bover, Amy Trinh, Isla Leslie, Kee H. Wong, Alan Melcher, Kate Newbold, Chris Nutting, Derfel ap Dafydd, Shreerang Bhide, Kevin J. Harrington

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT)

    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT) gan Lori J. Wirth, Makoto Tahara, Bruce Robinson, Sanjeev Francis, Marcia S. Brose, Mouhammed Amir Habra, Kate Newbold, Naomi Kiyota, Corina E. Dutcus, Elton Mathias, Matthew Guo, Steven I. Sherman, Martin Schlumberger

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck

    Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck gan Kevin J. Harrington, Mohan Hingorani, Mary Anne Tanay, Jennifer Hickey, Shreerang Bhide, Peter Clarke, Louise C. Renouf, Khin Thway, Amen Sibtain, Iain A. McNeish, Kate Newbold, Howard Goldsweig, Robert S. Coffin, Christopher M. Nutting

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with <sup>18</sup>F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma

    The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with <sup>18</sup>F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy... gan Kee H. Wong, Rafał Panek, Liam Welsh, Dualta Mcquaid, Alex Dunlop, Angela M. Riddell, Iain Murray, Yong Du, Sue Chua, Dow‐Mu Koh, Shreerang Bhide, Chris Nutting, Wim J.G. Oyen, Kevin J. Harrington, Kate Newbold

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer

    Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer gan Kee H. Wong, Rafał Panek, Alex Dunlop, Dualta Mcquaid, Angela M. Riddell, Liam Welsh, Iain Murray, Dow‐Mu Koh, Martin O. Leach, Shreerang Bhide, Christopher M. Nutting, Wim J.G. Oyen, Kevin J. Harrington, Kate Newbold

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

    DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in hea... gan Imran Petkar, Keith Rooney, Justin Roe, Joanne Patterson, D. Bernstein, Justine Tyler, Marie A. Emson, James P. Morden, Kathrin Mertens, Elizabeth Miles, Matthew Beasley, Tom Roques, Shreerang Bhide, Kate Newbold, Kevin J. Harrington, Emma Hall, Christopher M. Nutting

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers

    Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers gan Kevin J. Harrington, Eleni Karapanagiotou, Victoria Roulstone, Katie Twigger, Christine L. White, Laura Vidal, Debbie Beirne, Robin Prestwich, Kate Newbold, Merina Ahmed, Khin Thway, Christopher M. Nutting, Matt Coffey, Dean Harris, Richard G. Vile, Hardev Pandha, Johann S. de Bono, Alan Melcher

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: